These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1714155)

  • 1. [Possibilities of immunotherapy of colorectal cancers and pancreatic tumors].
    Klapdor R
    Z Gastroenterol Verh; 1991 Mar; 26():220-7. PubMed ID: 1714155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of colorectal cancers].
    Bécouarn Y; Seitz JF; Perrier H; Rouhier ML; Giovannini M; Brunet R
    Gastroenterol Clin Biol; 1996 Feb; 20(1):20-32. PubMed ID: 8734308
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant immunotherapy in colorectal cancer.
    Vermorken JB
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):66-71. PubMed ID: 11049049
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adjuvant therapy of liver metastases: active specific immunotherapy].
    Hagmüller E; Beck N; Ockert D; Schirrmacher V
    Zentralbl Chir; 1995; 120(10):780-5. PubMed ID: 7502592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can monoclonal antibodies to a carcinoma-specific cell surface molecule prevent liver metastasis of human colorectal carcinoma and effectively treat already existing micrometastases?].
    Burkart C; Porschen R
    Z Gastroenterol; 1996 Jan; 34(1):41-2. PubMed ID: 8776175
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy for treating metastatic colorectal cancer.
    Boghossian S; Robinson S; Von Delwig A; Manas D; White S
    Surg Oncol; 2012 Jun; 21(2):67-77. PubMed ID: 21292476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
    Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Missile therapy of colorectal and pancreatic cancers--clinical trial of monoclonal antibody, A7-NCS, in 73 patients with colorectal and pancreatic cancers].
    Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M; Otsuji E
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1111-9. PubMed ID: 2140933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer.
    Chen SJ; Wang SC; Chen YC
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancers of the large bowel and hepatobiliary system.
    Treat J; Ahlgren JD; Woolley PV
    Cancer Chemother Biol Response Modif; 1987; 9():264-70. PubMed ID: 2856336
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.
    Correale P; Cusi MG; Micheli L; Nencini C; Del Vecchio MT; Torino F; Aquino A; Bonmassar E; Francini G; Giorgi G
    Invest New Drugs; 2006 Mar; 24(2):99-110. PubMed ID: 16502353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunotherapy of colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from resected liver metastasis.
    Schirrmacher V; Schlag P; Liebrich W; Patel BT; Stoeck M
    Ann N Y Acad Sci; 1993 Aug; 690():364-6. PubMed ID: 8368757
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy after resection of hepatic colorectal metastases.
    Sandoval B; Fong Y
    Ann Surg Oncol; 2008 Jan; 15(1):9-10. PubMed ID: 18008107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy of colorectal cancer--overview and perspectives].
    Schimanski CC; Hörner V; Kanzler S; Galle PR; Moehler M
    Z Gastroenterol; 2006 Aug; 44(8):673-81. PubMed ID: 16902899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness.
    Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Marchesi F
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1219-28. PubMed ID: 25222571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of liver metastases: new horizons for biologically based therapy.
    Allendorf J; Ippagunta N; Emond J
    J Surg Res; 2004 Mar; 117(1):144-53. PubMed ID: 15013725
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gastroenterology 2010].
    Eickhoff A; Riemann JF
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1286-9. PubMed ID: 20556684
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
    Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
    Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.